We are live on ! Find out more
FPRX

Five Prime Therapeutics, Inc.
FPRX

Delisted

FPRX was delisted on the 15th of April, 2021.

Back to rankings

113 hedge funds and large institutions have $424M invested in Five Prime Therapeutics, Inc. in 2019 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 39 increasing their positions, 30 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

48% more capital invested

Capital invested by funds: $287M → $424M (+$137M)

30% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 30

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

3% less funds holding

Funds holding: 116 → 113 (-3)

17% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 18

35% less call options, than puts

Call options by funds: $1.35M | Put options by funds: $2.09M

Holders
113
Holders Change
-3
Holders Change %
-2.59%
% of All Funds
2.45%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
15
Increased
39
Reduced
30
Closed
18
Calls
$1.35M
Puts
$2.09M
Net Calls
-$740K
Net Calls Change
-$38K

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$7.42M
2
AC
Armistice Capital
New York
+$3.42M
3
BI
BVF Inc
California
+$3.23M
4
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale
Germany
+$3.11M
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$2.85M

Top Sellers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
-$3.04M
2
SI
Sofinnova Investments
California
-$2.93M
3
BlackRock
BlackRock
New York
-$2.52M
4
Millennium Management
Millennium Management
New York
-$1.84M
5
AllianceBernstein
AllianceBernstein
Tennessee
-$1.78M
Name Holding Trade Value Shares
Change 		Change in
Stake
OAM
26
Oxford Asset Management
United Kingdom
$2.48M -$1.15M -100,389 -35%
Bank of New York Mellon
27
Bank of New York Mellon
New York
$2.29M -$2.5K -219 -0.1%
Assenagon Asset Management
28
Assenagon Asset Management
Luxembourg
$2.07M +$1.76M +154,700 New
Two Sigma Advisers
29
Two Sigma Advisers
New York
$2.04M -$388K -34,000 -18%
Bank of America
30
Bank of America
North Carolina
$1.81M +$251K +22,024 +20%
Two Sigma Investments
31
Two Sigma Investments
New York
$1.79M -$1.35M -118,774 -47%
Goldman Sachs
32
Goldman Sachs
New York
$1.73M -$6.23K -546 -0.4%
Prudential Financial
33
Prudential Financial
New Jersey
$1.64M -$1.26M -110,721 -48%
Macquarie Group
34
Macquarie Group
Australia
$1.34M +$1.14M +100,000 New
Wells Fargo
35
Wells Fargo
California
$1.3M +$40.3K +3,532 +4%
AGA
36
Altrinsic Global Advisors
Connecticut
$1.21M – – –
Acadian Asset Management
37
Acadian Asset Management
Massachusetts
$1.16M +$986K +86,430 New
AA
38
ALPS Advisors
Colorado
$1.15M +$42.3K +3,707 +5%
WBC
39
Westpac Banking Corp
Australia
$915K +$154K +13,470 +25%
Jacobs Levy Equity Management
40
Jacobs Levy Equity Management
New Jersey
$910K +$154K +13,500 +25%
Swiss National Bank
41
Swiss National Bank
Switzerland
$843K – – –
California State Teachers Retirement System (CalSTRS)
42
California State Teachers Retirement System (CalSTRS)
California
$688K -$13.4K -1,178 -2%
AllianceBernstein
43
AllianceBernstein
Tennessee
$669K -$1.78M -155,900 -76%
RhumbLine Advisers
44
RhumbLine Advisers
Massachusetts
$648K -$3.38K -296 -0.6%
Rafferty Asset Management
45
Rafferty Asset Management
New York
$647K +$551K +48,287 New
Invesco
46
Invesco
Georgia
$604K +$17K +1,493 +3%
FAM
47
Fred Alger Management
New York
$603K +$513K +45,000 New
State of Wisconsin Investment Board
48
State of Wisconsin Investment Board
Wisconsin
$600K +$116K +10,200 +29%
AIM
49
Assured Investment Management
New York
$513K +$215K +18,875 +97%
New York State Common Retirement Fund
50
New York State Common Retirement Fund
New York
$482K – – –
1
2
3 4 5

FPRX Hedge Fund Activity: Q1 2019 in Review

113 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Five Prime Therapeutics, Inc. (FPRX) for Q1 2019, worth a combined $424M — up 48% from $287M a quarter earlier.

Sellers outnumbered buyers: 18 funds closed out of FPRX and 15 opened new positions — a net loss of 3 holders — while 30 trimmed existing stakes and 39 added.

The largest buyer was Vanguard Group, adding an estimated $7.42M. The largest seller was EcoR1 Capital, exiting entirely with an estimated $3.04M sold.

  • 113 institutional investors held Five Prime Therapeutics, Inc. (FPRX) as of Q1 2019, down from 116 in Q4 2018.
  • Funds reported $424M of Five Prime Therapeutics, Inc. stock for Q1 2019, up 48% quarter-over-quarter.
  • 15 funds opened new Five Prime Therapeutics, Inc. positions in Q1 2019 and 18 closed out, a net change of -3 holders.
  • The largest Five Prime Therapeutics, Inc. buyer in Q1 2019 was Vanguard Group, an estimated $7.42M added.
  • The largest Five Prime Therapeutics, Inc. seller in Q1 2019 was EcoR1 Capital, an estimated $3.04M sold.

Based on aggregated 13F filings for Q1 2019.